Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The insulin-like growth factor system in multiple sclerosis.
Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica.
Validity and test-retest reliability of a measure of hand sensibility and manual dexterity in people with multiple sclerosis: the ReSense test.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration: An Old Repair Program May Cause Myelin and Axon Perturbation under Nonlesion Conditions.
Progesterone's role in neuroprotection, a review of the evidence.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Mood and coping in clinically isolated syndrome and multiple sclerosis.
Modeling disease severity in multiple sclerosis using electronic health records.
Constraint-induced movement therapy: a method for harnessing neuroplasticity to treat motor disorders.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
Management of fingolimod-associated macular edema.
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
New immunological approaches in treating and diagnosing CNS diseases.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
[Disease modifying drugs in multiple sclerosis and pregnancy.]
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Nanotechnology in neurology: Genesis, current status, and future prospects.
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »